Heart Lung. 2026 Jan 8;78:102701. doi: 10.1016/j.hrtlng.2025.102701. Online ahead of print.ABSTRACTBACKGROUND: As survival improves for people with cystic fibrosis (PwCF) in the era of CFTR modulators, cardiovascular (CV) diseases are emerging as clinically important comorbidities. Beyond age-relate
Eur J Cardiothorac Surg. 2026 Jan 9:ezag014. doi: 10.1093/ejcts/ezag014. Online ahead of print.ABSTRACTOBJECTIVES: Left Ventricular Assist Devices have become an important therapy for advanced heart failure. We present 2-year results of the prospective, multicentre clinical trial in China, showing l
JMIR Form Res. 2026 Jan 9;10:e78484. doi: 10.2196/78484.ABSTRACTBACKGROUND: Cardiac arrest (CA), characterized by an extremely high mortality rate, remains one of the most pressing global public health challenges. It not only causes a substantial strain on health care systems but also severely impac
Am J Physiol Heart Circ Physiol. 2026 Jan 9. doi: 10.1152/ajpheart.00646.2025. Online ahead of print.ABSTRACTSex differences in cardiovascular disease are well documented, with females often considered hormonally protected. However, some differences persist even after menopause, indicating non-hormo
Am J Manag Care. 2025 Dec;31(Spec. No. 15):SP1084-SP1085. doi: 10.37765/ajmc.2025.89854.ABSTRACTThe recent endorsement of glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide (Wegovy), by the American College of Cardiology as first-line therapy for weight management marks a paradig
Alzheimers Dement. 2025 Dec;21 Suppl 2:e105227. doi: 10.1002/alz70856_105227.ABSTRACTBACKGROUND: Cerebral amyloid angiopathy (CAA) is a cerebrovascular disorder characterized by the deposition of amyloid-β (Aβ) in the walls of leptomeningeal and cortical blood vessels leading to increased risk of mi
Alzheimers Dement. 2025 Dec;21 Suppl 2:e105585. doi: 10.1002/alz70856_105585.ABSTRACTBACKGROUND: Alzheimer's disease (AD) is one of the most prevalent causes of dementia, while concomitant diseases such as cerebral amyloid angiopathy (CAA) has a substantial impact on clinical trajectories and therap
Neurology. 2026 Feb 10;106(3):e214577. doi: 10.1212/WNL.0000000000214577. Epub 2026 Jan 9.ABSTRACTBACKGROUND AND OBJECTIVES: The optimal blood pressure (BP) target after endovascular thrombectomy (EVT) remains elusive. The aim of our study was to assess the relationship between individualized autore
Neurology. 2026 Feb 10;106(3):e214569. doi: 10.1212/WNL.0000000000214569. Epub 2026 Jan 9.ABSTRACTBACKGROUND AND OBJECTIVES: Infants with critical congenital heart disease (CHD) are at increased risk of brain injury and neurodevelopmental impairments, with variable rates of ischemic brain injury rep
J Med Internet Res. 2026 Jan 9;28:e78492. doi: 10.2196/78492.ABSTRACTBACKGROUND: Whether the benefits of identical physical activity (PA) patterns for adults with high blood pressure (BP) vary according to an individual's characteristics has not been adequately studied.OBJECTIVE: This study aimed to
Rev Esc Enferm USP. 2026 Jan 9;59:e20250053. doi: 10.1590/1980-220X-REEUSP-2025-0053en. eCollection 2026.ABSTRACTOBJECTIVE: To map the evidence on continuity of care for people with systemic arterial hypertension in Primary Health Care (PHC), pointing out limitations and strategies for its implement
Eur J Cardiovasc Nurs. 2026 Jan 9:zvag008. doi: 10.1093/eurjcn/zvag008. Online ahead of print.ABSTRACTThis paper discusses whether there is a need to upskill nurses and allied professionals in light of recent developments in ribonucleic acid-based therapeutics (RNA-Tx) for cardiovascular disease (CV
Proc Natl Acad Sci U S A. 2026 Jan 13;123(2):e2512853123. doi: 10.1073/pnas.2512853123. Epub 2026 Jan 9.ABSTRACTSphingosine 1-phosphate (S1P) is a bioactive lipid that circulates in plasma bound to high-density lipoproteins (HDL) and albumin. Circulating S1P levels correlate positively with systolic
Proc Natl Acad Sci U S A. 2026 Jan 13;123(2):e2521757123. doi: 10.1073/pnas.2521757123. Epub 2026 Jan 9.ABSTRACTIschemic white matter damage is a significant pathological feature of chronic cerebral hypoperfusion, leading to cognitive impairments. However, the underlying molecular mechanisms remain
PLoS One. 2026 Jan 9;21(1):e0340287. doi: 10.1371/journal.pone.0340287. eCollection 2026.ABSTRACTBACKGROUND: Near real-time electronic health record (EHR) data offers significant potential for secondary use in research, operations, and clinical care, yet challenges remain in ensuring data quality an
PLoS One. 2026 Jan 9;21(1):e0340382. doi: 10.1371/journal.pone.0340382. eCollection 2026.ABSTRACTBACKGROUND: Triggering receptor expressed on myeloid cells-1 (TREM-1) is a potent amplifier of inflammatory responses and plays a critical role in the pathogenesis of various infectious diseases. Notably
Fam Pract. 2025 Dec 9;43(1):cmaf097. doi: 10.1093/fampra/cmaf097.ABSTRACTBACKGROUND: This cross-sectional study aimed to describe proportions of patients with indications of alcohol consumption using phosphatidylethanol (PEth), the Alcohol Use Disorders Identification Test (AUDIT), and its consumpti
Br J Surg. 2025 Dec 24;113(1):znaf279. doi: 10.1093/bjs/znaf279.ABSTRACTBACKGROUND: Aortic arch pathologies are complex to treat. Alternatives include open surgery, hybrid surgery (endovascular aortic stent-grafting and open surgical debranching procedures) and total endovascular solutions with bran
South Med J. 2026 Jan;119(1):44-48. doi: 10.14423/SMJ.0000000000001921.ABSTRACTAnorexia nervosa (AN) is a severe psychiatric disorder with profound cardiovascular consequences, including QT interval prolongation and bradycardia. These abnormalities contribute to an increased risk of life-threatening
South Med J. 2026 Jan;119(1):39-43. doi: 10.14423/SMJ.0000000000001925.ABSTRACTThe rapid evolution of genomic technologies is poised to transform patient care during the next decade, integrating precision medicine with artificial intelligence (AI) to enhance diagnostic accuracy, therapeutic decision
JAMA Netw Open. 2026 Jan 2;9(1):e2553323. doi: 10.1001/jamanetworkopen.2025.53323.ABSTRACTIMPORTANCE: The association of bariatric surgery and newer glucagon-like peptide-1 receptor agonists (GLP-1RAs; semaglutide and tirzepatide) with body composition still lack evidence from clinical settings.OBJE
Clin Exp Rheumatol. 2026 Jan 7. doi: 10.55563/clinexprheumatol/6pstix. Online ahead of print.ABSTRACTOBJECTIVES: Systemic sclerosis (SSc) is a chronic autoimmune disease characterised by skin and internal organ involvement. Despite the acknowledgment that cardiovascular (CV) complications are a lead
Egypt Heart J. 2026 Jan 9;78(1):2. doi: 10.1186/s43044-025-00712-5.ABSTRACTBACKGROUND: Only a limited number of studies have reported on TOF with absent pulmonary valve (APV). Similarly, while cases of TOF with absent pulmonary artery (PA) have been documented, case reports describing TOF with both
Curr Med Sci. 2026 Jan 9. doi: 10.1007/s11596-025-00153-w. Online ahead of print.ABSTRACTOBJECTIVE: Cardiovascular disease (CVD) is the leading cause of mortality in patients with end-stage renal disease (ESRD) undergoing maintenance dialysis. To further clarify this critical relationship, we conduc
